Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Twist Bioscience and Kyowa Kirin Partner for GPCR Antibody Discovery
Friday, March 26, 2021Twist Bioscience Corporation a company enabling customers to succeed through its offering of highquality synthetic DNA using its silicon platform today announced that it signed a partnership agreement with Kyowa Kirin Pharmaceutical Research Inc a su...
Bright Peak Therapeutics Inc. and Ajinomoto Co., Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines
Friday, March 26, 2021Bright Peak Therapeutics Inc a biotechnology company developing next generation immunotherapies for cancer and autoimmune disease and Ajinomoto Co Inc Ajinomoto Co a leading technology provider for biopharmaceuticals and the owner of Ajinomoto BioPha...
Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies
Thursday, March 25, 2021A broad coalition of biopharmaceutical and technology leaders announced a new strategic collaboration to promote new and updated standards for advanced therapies The new collaboration which will work across the biopharmaceutical and technology sector...
Exacis Biotherapeutics Develops mRNA-Engineered iPSC-Derived NK Cells For Difficult-To-Treat Tumors
Thursday, March 25, 2021Exacis Biotherapeutics Inc a developmentstage immunooncology company working to democratize access to the most advanced and effective cancer treatments announced several important steps in the preclinical development of its ExaNK engineered NK cellth...
Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats
Wednesday, March 24, 2021Cipla Therapeutics a division of Cipla USA Inc an affiliate of Cipla Limitedand SIGA Technologies Inc a commercialstage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained...
Dunad Therapeutics Emerges To Develop Next-generation Small Molecule Therapeutics Based On First Tuneable Targeted Protein Degradation Technology
Wednesday, March 24, 2021Dunad Therapeutics Dunad emerges to develop nextgeneration small molecule therapeutics based on its highly differentiated tuneable and targeted protein degradation technology Dunad secured initial financing from Epidarex Capital
SemaThera enters into exclusive research collaboration and licensing agreement with Roche
Tuesday, March 23, 2021SemaThera Inc announced the signing of a multiyear research collaboration and license agreement with Roche The partnership will focus on the development of a promising new class of SemaThera biologics for the treatment of diabetic retinopathy and oth...
Relief and Acer Therapeutics Sign Collaboration and License Agreement for Worldwide Development and Commercialization of ACER-001
Tuesday, March 23, 2021RELIEF THERAPEUTICS Holding AG a biopharmaceutical company with its lead compound RLF aviptadil in advanced clinical development to treat severe COVID patients and Acer Therapeutics Inc a pharmaceutical company focused on the acquisition development...
Everest Medicines Announces Acceptance of New Drug Application by China NMPA for Xerava™ for the Treatment of Complicated Intra-abdominal Infections
Monday, March 22, 2021Everest Medicines a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia
Indivumed announces expansion into drug development and reports the formation of Ix Therapeutics
Saturday, March 20, 2021Indivumed GmbH Indivumed announced together with Xlife Sciences AG Xlife Sciences the establishment of the Ix Therapeutics GmbH Ix Therapeutics joint venture Indivumans expansion into target cancer discovery and drug development bringing entirely new...
